TrialNeurology2019
Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial.
Lon S Schneider et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this paperpooled itcites it
TrialNeurology2019
Lon S Schneider et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.